tiprankstipranks
Radiopharm Theranostics Limited (AU:RAD)
ASX:RAD
Australian Market

Radiopharm Theranostics Limited (RAD) Income Statement

Compare
13 Followers

Radiopharm Theranostics Limited Income Statement

Last quarter (Q4 2024), Radiopharm Theranostics Limited's total revenue was AU$-1.05M, a decrease of -208.15% from the same quarter last year. In Q4, Radiopharm Theranostics Limited's net income was AU$-23.19M. See Radiopharm Theranostics Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21
Total Revenue
AU$ 299.23KAU$ 292.36KAU$ 8.83KAU$ 0.00
Gross Profit
AU$ -21.31MAU$ -3.00MAU$ -2.97MAU$ 0.00
Operating Expenses
AU$ 299.23KAU$ 37.29MAU$ 20.95MAU$ 484.75K
Depreciation and Amortization
AU$ 3.13MAU$ 3.30MAU$ 2.98MAU$ 1.16M
EBITDA
AU$ -45.38MAU$ -31.19MAU$ -18.04MAU$ -484.75K
Operating Income
AU$ -36.62MAU$ -40.29MAU$ -23.93MAU$ -484.75K
Other Income/Expenses
AU$ -11.23MAU$ -6.00MAU$ -10.38MAU$ 679.27K
Pretax Income
AU$ -47.85MAU$ -40.49MAU$ -30.29MAU$ -485.19K
Net Income
AU$ -47.95MAU$ -34.61MAU$ -30.34MAU$ -485.19K
Per Share Metrics
AU$ ―AU$ ―AU$ ―AU$ ―
Basic EPS
AU$ -0.12AU$ -0.11AU$ -0.11AU$ 0.00
Diluted EPS
AU$ -0.12AU$ -0.11AU$ -0.11AU$ 0.00
Weighted Average Shares Outstanding
386.46M 323.82M 279.77M 277.47M
Weighted Average Shares Outstanding (Diluted)
386.46M 323.82M 279.77M 277.47M
Currency in AUD

Radiopharm Theranostics Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis